Genotoxicity evaluation in chronic renal patients undergoing hemodialysis and peritoneal dialysis, using the micronucleus test

Genetics and Molecular Research

Volumn 7, Issue 2, 2008, Pages 433-443

  Roth, J M ^a   Restani, R G ^b   Goncalves T T S ^b   Sphor, S L S ^b   Ness, A B ^b   Martino Roth, M G ^b   Garcias, G L ^a,b  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Chronic renal disease; Hemodialysis patients; Micronucleus; Mutagenicity; Peritoneal dialysis patients

Indexed keywords

CREATINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHROMOSOME LOSS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENETIC DAMAGE; GENOTOXICITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; MICRONUCLEUS TEST; OXIDATIVE STRESS; PERITONEAL DIALYSIS; SMOKING; TREATMENT DURATION;

EID: 47949117137     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol7-2gmr441     Document Type: Article

References (24)

1. Ajzen H and Schor N (2002). Guias de Medicina Ambulatorial e Hospitalar/Unifesp - Nefrologia. Manole, Barueri.
2. Au WW (1991). Cytogenetic assays in monitoring human exposure and prediction of risk. Environ. Mutagen. Carcinogen. Teratogen. 23: 236-245.
3. Barros E, Manfro RC and Thomé F (1999). Nefrologia: rotina, diagnóstico e tratamento. Artmed, Porto Alegre, 475-497.
4. Carrano AV and Natarajan AT (1988). Considerations for population monitoring using cytogenetic techniques. Mutat. Res. 204: 379-406.
5. Combe C, McCullough KP, Asano Y, Ginsberg N, et al. (2004). Kidney disease outcomes quality initiative (K/DOQI) and the dialysis outcomes and practice patterns study (DOPPS): nutrition guidelines, indicators, and practices. Am. J. Kidney Dis. 44: 39-46.
6. De Flora S (1998). Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 402: 151-158.
7. Goodkin DA, Young EW, Kurokawa K, Prutz KG, et al. (2004). Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am. J. Kidney Dis. 44: 16-21.
8. Gotloib L, Wajsbrot V and Shostak A (2003). Icodextrin-induced lipid peroxidation disrupts the mesothelial cell cycle engine. Free Radic. Biol. Med. 34: 419-428.
9. Guyton AC and Hall JE (2002). Tratado de Fisiologia Médica. Guanabara Koogan, Rio de Janeiro.
10. Ha H, Yu MR, Choi HN, Cha MK, et al. (2000). Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit. Dial. Int. 20 (Suppl. 5): S10-S18.
11. Hayashi M, Tice RR, MacGregor JT, Anderson D, et al. (1994). In vivo rodent erythrocyte micronucleus assay. Mutat. Res. 312: 293-304.
12. Ishibashi Y, Sugimoto T, Ichikawa Y, Akatsuka A, et al. (2002). Glucose dialysate induces mitochondrial DNA damage in peritoneal mesothelial cells. Perit. Dial. Int. 22: 11-21.
13. Kan E, Undeger U, Bali M and Basaran N (2002). Assessment of DNA strand breakage by the alkaline Comet assay in dialysis patients and the role of vitamin E supplementation. Mutat. Res. 520: 151-159.
14. Liu CS, Ko LY, Lim PS, Kao SH, et al. (2001). Biomarkers of DNA damage in patients with end-stage renal disease: mitochondrial DNA mutation in hair follicles. Nephrol. Dial. Transplant. 16: 561-565.
15. Maluf SW and Erdtmann B (2000). Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis assay. Mutat. Res. 471: 21-27.
16. Markert M, Heierli C, Kuwahara T, Frei J, et al. (1988). Dialyzed polymorphonuclear neutrophil oxidative metabolism during dialysis: a comparative study with 5 new and reused membranes. Clin. Nephrol. 29: 129-136.
17. Picker JD and Fox DP (1986). Do curried foods produce micronuclei in buccal epithelial cells? Mutat. Res. 171: 185-188.
18. Riella MC (1996). Princípios de Nefrologia e Distúrbios Hidroeletrolíticos. Guanabara Koogan, Rio de Janeiro.
19. Ross EA, Koo LC and Moberly JB (1997). Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am. J. Kidney Dis. 30: 489-494.
20. Stopper H, Meysen T, Bockenforde A, Bahner U, et al. (1999). Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am. J. Kidney Dis. 34: 433-437.
21. Stopper H, Boullay F, Heidland A, Vienken J, et al. (2001). Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. Am. J. Kidney Dis. 38: 296-301.
22. Stopper H, Schupp N, Bahner U, Sebekova K, et al. (2004). Genomic damage in end-stage renal failure: potential involvement of advanced glycation end products and carbonyl stress. Semin. Nephrol. 24: 474-478.
23. Tarng DC, Wen CT, Huang TP, Chen CL, et al. (2002). Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J. Am. Soc. Nephrol. 13: 1321-1330.
24. Wieczorowska-Tobis K, Polubinska A, Schaub TP, Schilling H, et al. (2001). Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats. Perit. Dial. Int. 21 (Suppl. 3): S108-S113.